{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:30Z","timestamp":1787069310477,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2015-AdG-694722"],"award-info":[{"award-number":["ERC-2015-AdG-694722"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuropharm.2025.110722","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:20:20Z","timestamp":1760743220000},"page":"110722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials"],"prefix":"10.1016","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7992-3603","authenticated-orcid":false,"given":"Luisa","family":"Prochazkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5012-7065","authenticated-orcid":false,"given":"Dominique Patrick","family":"Lippelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Schon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kucha\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-5125","authenticated-orcid":false,"given":"Bernhard","family":"Hommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2025.110722_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: definition, pitfalls, and adjustment methods","volume":"9","author":"Althubaiti","year":"2016","journal-title":"J. Multidiscip. Healthc."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110722_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-019-0308-4","article-title":"Psychedelic microdosing benefits and challenges: an empirical codebook","volume":"16","author":"Anderson","year":"2019","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.neuropharm.2025.110722_bib41","doi-asserted-by":"crossref","first-page":"832375","DOI":"10.3389\/fnins.2022.832375","article-title":"Psychedelic cognition\u2014the unreached frontier of psychedelic science","volume":"16","author":"B\u0103l\u0103e\u0163","year":"2022","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110722_bib3","first-page":"461","article-title":"Preliminary report on the effects of a low dose of LSD on resting- state amygdala functional connectivity","volume":"5","author":"Bershad","year":"2020","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110722_bib4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","article-title":"Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers","volume":"86","author":"Bershad","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tics.2011.12.010","article-title":"The variable nature of cognitive control: a dual-mechanisms framework","volume":"16","author":"Braver","year":"2012","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2025.110722_bib42","doi-asserted-by":"crossref","first-page":"105233","DOI":"10.1016\/j.cognition.2022.105233","article-title":"Humans adaptively resolve the explore-exploit dilemma under cognitive constraints: evidence from a multi-armed bandit task","volume":"229","author":"Brown","year":"2022","journal-title":"Cognition"},{"key":"10.1016\/j.neuropharm.2025.110722_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110722_bib6","series-title":"Clinical Trials Week","first-page":"611","article-title":"Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity","author":"Cavanna","year":"2021"},{"key":"10.1016\/j.neuropharm.2025.110722_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41398-022-02039-0","article-title":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","volume":"12","author":"Cavanna","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110722_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fpsyg.2011.00279","article-title":"Positive affect versus reward: emotional and motivational influences on cognitive control","volume":"2","author":"Chiew","year":"2011","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3758\/s13415-014-0280-0","article-title":"Dissociable influences of reward motivation and positive emotion on cognitive control","volume":"14","author":"Chiew","year":"2014","journal-title":"Cognit. Affect Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110722_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2013.00200","article-title":"Working memory reloaded: tyrosine repletes updating in the N-back task","volume":"7","author":"Colzato","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110722_bib9","author":"de Wit"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110722_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10608-009-9276-4","article-title":"The cognitive flexibility inventory: instrument development and estimates of reliability and validity","volume":"34","author":"Dennis","year":"2010","journal-title":"Cognit. Ther. Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110722_bib55","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/npp.2016.82","article-title":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","volume":"41","author":"Dolder","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0278-7393.30.2.343","article-title":"How positive affect modulates cognitive control: reduced perseveration at the cost of increased distractibility","volume":"30","author":"Dreisbach","year":"2004","journal-title":"J. Exp. Psychol. Learn. Mem. Cognit."},{"key":"10.1016\/j.neuropharm.2025.110722_bib11","series-title":"Lecture Presented at the Psychedelic Science 2017 Conference","article-title":"Microdosing: the phenomenon, research results, and startling surprises","author":"Fadiman","year":"2017"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","article-title":"Might microdosing psychedelics be safe and beneficial? An initial exploration","volume":"51","author":"Fadiman","year":"2019","journal-title":"J. Psychoact. Drugs"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110722_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low-dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology (Berlin)"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110722_bib54","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1073\/pnas.1918477117","article-title":"Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings","volume":"117","author":"Forstmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3758\/s13415-014-0259-x","article-title":"The differential influences of positive affect, random reward, and performance-contingent reward on cognitive control","volume":"14","author":"Fr\u00f6ber","year":"2014","journal-title":"Cognit. Affect Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1037\/xlm0000166","article-title":"How sequential changes in reward magnitude modulate cognitive flexibility: evidence from voluntary task switching","volume":"42","author":"Fr\u00f6ber","year":"2016","journal-title":"J. Exp. Psychol. Learn. Mem. Cognit."},{"key":"10.1016\/j.neuropharm.2025.110722_bib13","article-title":"LSD microdosing: the new job enhancer in Silicon Valley and beyond","author":"Glatter","year":"2015","journal-title":"Forbes"},{"key":"10.1016\/j.neuropharm.2025.110722_bib43","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3389\/fpsyg.2016.01822","article-title":"Inducing proactive control shifts in the AX-CPT","volume":"7","author":"Gonthier","year":"2016","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neuropharm.2025.110722_bib14","first-page":"33","article-title":"Between persistence and flexibility: the Yin and Yang of action control","volume":"vol. 2","author":"Hommel","year":"2015"},{"key":"10.1016\/j.neuropharm.2025.110722_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neubiorev.2017.01.009","article-title":"The social transmission of metacontrol policies: mechanisms underlying the interpersonal transfer of persistence and flexibility","volume":"81","author":"Hommel","year":"2017","journal-title":"Neurosci. BioBehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110722_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2020.10.002","article-title":"Mood and cognition after administration of low LSD doses in healthy volunteers: a placebo-controlled dose-effect finding study","volume":"41","author":"Hutten","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2025.110722_bib48","series-title":"Handbook of emotions","first-page":"548","article-title":"Some ways in which positive affect influences decision making and problem solving","author":"Isen","year":"2008"},{"key":"10.1016\/j.neuropharm.2025.110722_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.11.008","article-title":"Microdosing psychedelics: motivations, subjective effects and harm reduction","volume":"75","author":"Lea","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110722_bib18","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-020-05477-0","article-title":"Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders","volume":"237","author":"Lea","year":"2020","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110722_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3758\/CABN.8.1.99","article-title":"Motivational influences on cognitive control: behavior, brain activation, and individual differences","volume":"8","author":"Locke","year":"2008","journal-title":"Cognit. Affect Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110722_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/02698811211050556","article-title":"Psilocybin microdosing does not affect emotion-related symptoms and processing: a preregistered field and lab-based study","volume":"36","author":"Marschall","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/02791072.2019.1580804","article-title":"Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being","volume":"51","author":"Mason","year":"2019","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2025.110722_bib20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41386-023-01772-4","article-title":"Greater subjective effects of a low dose of LSD in participants with depressed mood","volume":"49","author":"Molla","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110722_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.concog.2008.12.008","article-title":"Meditation, mindfulness and cognitive flexibility","volume":"18","author":"Moore","year":"2009","journal-title":"Conscious. Cognit."},{"key":"10.1016\/j.neuropharm.2025.110722_bib21","article-title":"Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide","volume":"241","author":"Murphy","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110722_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/15298860309027","article-title":"Development and validation of a scale to measure self-compassion","volume":"2","author":"Neff","year":"2003","journal-title":"Self Identity"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cpt.557","article-title":"Psychedelics as medicines: an emerging new paradigm","volume":"101","author":"Nichols","year":"2017","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110722_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/02698811241254831","article-title":"Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research","volume":"38","author":"Polito","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110722_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211023","article-title":"A systematic study of microdosing psychedelics","volume":"14","author":"Polito","year":"2019","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.neuropharm.2025.110722_bib56","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1523\/JNEUROSCI.1939-17.2018","article-title":"Role of the 5-HT\u2082A receptor in self- and other-initiated social interaction in LSD-induced states","volume":"38","author":"Preller","year":"2018","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110722_bib25","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","article-title":"Exploring the effect of microdosing psychedelics on creativity in an open- label natural setting","volume":"235","author":"Prochazkova","year":"2018","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110722_bib53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1073191116645905","article-title":"Disentangling components of flexibility via the hexaflex model: development and validation of the Multidimensional Psychological Flexibility Inventory (MPFI)","volume":"25","author":"Rolffs","year":"2018","journal-title":"Assessment"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110722_bib47","doi-asserted-by":"crossref","first-page":"22479","DOI":"10.1038\/s41598-021-01811-4","article-title":"Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers","volume":"11","author":"Rootman","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110722_bib40","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neuron.2022.12.031","article-title":"The costs and benefits of psychedelics on cognition and mood","volume":"111","author":"Sayal\u0131","year":"2023","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110722_bib39","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3758\/s13414-010-0065-7","article-title":"Increases in rewards promote flexible behavior","volume":"73","author":"Shen","year":"2011","journal-title":"Atten. Percept. Psychophys."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110722_bib49","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1371\/journal.pbio.0050138","article-title":"Mental training affects distribution of limited brain resources","volume":"5","author":"Slagter","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2025.110722_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","article-title":"Self-blinding citizen science to explore psychedelic microdosing","volume":"10","author":"Szigeti","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110722_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-7525-5-63","article-title":"The Warwick\u2013Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation","volume":"5","author":"Tennant","year":"2007","journal-title":"Health Qual. Life Outcome"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110722_bib29","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00213-021-05857-0","article-title":"Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study","volume":"239","author":"van Elk","year":"2021","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110722_bib57","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.paid.2005.11.025","article-title":"Measuring mindfulness \u2014 The Freiburg Mindfulness Inventory (FMI)","volume":"40","author":"Walach","year":"2006","journal-title":"Pers. Indiv. Differ."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110722_bib52","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: The PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J. Personality Soc. Psychol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110722_bib30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","article-title":"The effects of microdose LSD on time perception: a randomised, double- blind, placebo-controlled trial","volume":"236","author":"Yanakieva","year":"2018","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110722_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/jmla.2002.2864","article-title":"The nature of recollection and familiarity: a review of 30 years of research","volume":"46","author":"Yonelinas","year":"2002","journal-title":"J. Mem. Lang."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:20:09Z","timestamp":1780820409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825004307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S0028390825004307"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110722","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110722"}}